NCT00004814View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 31, 1991

Conditions
Multiple Sclerosis
Interventions
DRUG

copolymer 1

All Listed Sponsors
collaborator

University of Maryland

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004814 - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis | Biotech Hunter | Biotech Hunter